Living donor liver transplantation in patients with hepatitis C

Liver Transplantation

Volumn 9, Issue 11, 2003, Pages

  Zimmerman, Michael A ^a   Trotter, James F ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ANTIVIRUS AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; PEGINTERFERON ALPHA2A; RECOMBINANT ERYTHROPOIETIN; RIBAVIRIN;

ARTICLE; DISEASE SEVERITY; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIVER; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; NONHUMAN; PHYSIOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; RECURRENT DISEASE; RECURRENT INFECTION; SIDE EFFECT; TREATMENT INDICATION; VIROLOGY; VIRUS PATHOGENESIS;

EID: 0242539726     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50256     Document Type: Article

References (23)

1. Rosen HR, Martin P. Hepatitis B and C in the liver transplant recipient. Semin Liver Dis 2000;20:465-480.
2. Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002;346:1074-1082.
3. Miller CM, Gondolesi GE, Florman S, Masumoto C, Munoz L, Yoshizumi T, et al. One hundred nine living donor liver transplants in adults and children: A single-center experience. Ann Surg 2001;234:301-311.
4. Marcos A. Right-lobe living donor liver transplantation. Liver Transpl 2000;6(suppl):S59-S63.
5. Ghobrial RM, Amersi F, Farmer DG, Chen P, Anselmo DM, Baquerizo A, et al. Rapid and severe early HCV recurrence following adult living donor liver transplantation [abstract]. Am J Transplant 2002;2:163A.
6. Gaglio PJ, Malireddy S, Russo M, Lapointe-Rudow D, Emond JC, Brown RS. Hepatitis C recurrence in recipients of grafts from living vs cadaveri liver donors [abstract]. Hepatology 2002;36: 265A.
7. Trotter JF, Schiano T, Wachs M, Kim-Schluger L, Bak T, Everson G, et al. Preliminary report: Hepatitis C occurs earlier and is more severe in living donor liver transplant recipients [abstract]. Am J Transplant 2001;1:316A.
8. Manez R, Mateo R, Tabasco J, Kusne S, Starzl TE, Duquesnoy RJ. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995;59:640-642.
9. Cotler SJ, Gaur LK, Gretch DR, Wile M, Strong DM, Bronner MP, et al. Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. Tissue Antigens 1998;52:435-443.
10. Nery J, Esquenazi V, Weppler D, Gomez C, Cirocco R, Gharagozloo H, et al. Hepatitis C in liver transplantation: Preliminary study of prognostic factors. Transpl Int 1994;7(suppl):S229-S231.
11. Belli LS, Zavaglia C, Alberti AB, Poli F, Rondinara G, Silini E, et al. Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation. Hepatology 2000;31:1345-1350.
12. Liu LU, Schiano TD, Trotter JF, Bodian C, Kim-Schluger L, Korman JD, et al. Differences in cellular rejection rates between living donor and cadaveric liver transplant recipients [abstract]. Hepatology 2001;34:234A.
13. Takatsuki M, Uemoto S, Inomata Y, Egawa H, Kiuchi T, Fujita S, et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 2001;72:449-454.
14. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998;28:823-830.
15. Kam I. Adult-adult right hepatic lobe living donor liver transplantation for status 2A patients: Too little, too late. Liver Transpl 2002;8:347-349.
16. Honda M, Kaneko S, Matsushita E, Kobayashi K, Abell GA, Lemon SM. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology 2000;118:152-162.
17. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low-density lipoprotein receptor. Proc Natl Acad Sci U S A 1999;96:12766-12771.
18. Monazahian M, Bohme I, Bonk S, Koch A, Scholz C, Grethe S, Thomssen R. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol 1999;57:223-229.
19. Pak YK Kamuch MP, Berrios D, Briggs MR, Cooper AD, Ellsworth JL. Activation of LDL receptor gene expression in HepG2 cells by hepatocyte growth factor. J Lipid Res 1996;37:985-998.
20. Bocchetta M, Bruscalupi G, Castellan F, Trentalance A, Komaromy M, Fong LG, Cooper AD. Early induction of LDL receptor gene during rat liver regeneration. J Cell Physiol 1993;156: 601-609.
21. Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Nerwork-Transplant Data: 1991-2001. UNOS, Richmond, VA, and the Division of Transplantation, Bureau of Health Resources and Services Administration, US Department of Health and Human Services, Rockville, MD, 2001. Available at: www.ustransplant.org. Accessed: January 15, 2003.
22. Everson GT, Trouillot T, Trotter JF, Skilbred J, Halprin A, McKinley C, et al. Treatment of decompensated cirrhotics with a low-accelerating dose regimen of interferon alfa-2B plus ribavirin: Safety and efficacy [abstract]. Hepatology 32:308A, 2000.
23. Halperin A, Trotter J, Everson G, Wachs M, Bak T, Kugelmas M, Kam I. Post-transplant eradication of hepatitis C by pretransplant treatment in living donor liver transplant recipients [abstract]. Hepatology 2001:34:244A.